Cargando…

Role of TGF-β signaling in uterine carcinosarcoma

Uterine carcinosarcomas (UCS) are rare (3-4%) but highly aggressive, accounting for a disproportionately high (16.4%) mortality among uterine malignancies. Transforming growth factor beta (TGFβ) is a multifunctional cytokine that regulates important cellular processes including epithelial-mesenchyma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhar Dwivedi, Shailendra Kumar, McMeekin, Scott D., Slaughter, Katrina, Bhattacharya, Resham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546494/ https://www.ncbi.nlm.nih.gov/pubmed/25918253

Ejemplares similares

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2015)

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
por: Xiong, Xunhao, et al.
Publicado: (2014)

A role for the cystathionine-β-synthase /H(2)S axis in astrocyte dysfunction in the aging brain
por: Dey, Anindya, et al.
Publicado: (2023)

Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017)

Role of MRI in uterine didelphys with co-existing endometrial carcinosarcoma
por: McGregor, Jill, et al.
Publicado: (2018)

Bmi-1: At the crossroads of physiological and pathological biology
por: Bhattacharya, Resham, et al.
Publicado: (2015)

Corrigendum to ‘Bmi-1: At the crossroads of physiological and pathological biology’ [Genes & Diseases 2 (2015) 225–239]
por: Bhattacharya, Resham, et al.
Publicado: (2015)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Trends of uterine carcinosarcoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Small Non-Coding-RNA in Gynecological Malignancies
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2021)

TGFβ superfamily signaling and uterine decidualization
por: Ni, Nan, et al.
Publicado: (2017)

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas
por: Lopez, Salvatore, et al.
Publicado: (2020)

Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2
por: Dey, Anindya, et al.
Publicado: (2020)

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas
por: McConechy, Melissa K, et al.
Publicado: (2015)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
por: Iavazzo, C., et al.
Publicado: (2013)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
por: Lodetti, Giorgia, et al.
Publicado: (2023)

The prognostic significance of the heterologous component in uterine carcinosarcomas
por: Can, Behzat, et al.
Publicado: (2023)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma
por: Inoue, H, et al.
Publicado: (2017)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Carcinosarcoma of the uterine cervix arising from Müllerian ducts
por: Kim, Myounghwan, et al.
Publicado: (2015)

Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy
por: Tan, Zhen, et al.
Publicado: (2017)

Brain Metastasis in a Young Patient with Uterine Carcinosarcoma
por: Katiyar, Vatsala, et al.
Publicado: (2019)

Clinical utility of CA-125 in the management of uterine carcinosarcoma
por: Matsuo, Koji, et al.
Publicado: (2018)

Uterine Carcinosarcoma: A Case Report and Literature Review
por: Kord, Ali, et al.
Publicado: (2020)

The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
por: Moukarzel, Lea A., et al.
Publicado: (2021)

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2021)

Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
por: Imo, Chinonye S., et al.
Publicado: (2022)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
por: Gracia, Myriam, et al.
Publicado: (2023)

Gemcitabine and Selected mTOR Inhibitors in Uterine Sarcomas and Carcinosarcoma Cells- an Isobolographic Analysis
por: Bobiński, Marcin, et al.
Publicado: (2020)

MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation
por: Kunc, Michal, et al.
Publicado: (2019)

BMI1, a new target of CK2α
por: Banerjee Mustafi, Soumyajit, et al.
Publicado: (2017)

The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress
por: Bhattacharya, Udayan, et al.
Publicado: (2022)

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma
por: Park, Hae Jin, et al.
Publicado: (2011)

Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas
por: Gungorduk, Kemal, et al.
Publicado: (2015)

Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives
por: Vitale, Salvatore Giovanni, et al.
Publicado: (2017)

OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma
por: An, Yang, et al.
Publicado: (2020)

Cancer antigen 125 is associated with disease status in uterine carcinosarcoma
por: Ross, Malcolm Strachan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9en59g8s3pc3gnvmgchtaq94en